Literature DB >> 7800956

Exercise hypoxemia and the effects of increased inspiratory oxygen concentration in severe chronic obstructive pulmonary disease.

W Mitlehner1, W Kerb.   

Abstract

Exercise-associated oxygen desaturation in severe chronic obstructive pulmonary disease (COPD) remains a topic of unknown prognostic and clinical relevance and of unknown therapeutic importance. Furthermore, exercise limitation in these patients is due to multifactorial interaction of respiratory, cardiac, circulatory and 'peripheral' mechanisms. For the evaluation of the role of the oxygen-dependent mechanisms of exercise limitation we studied 14 stable patients with severe COPD (FEV1 32% pred., FEV1/VC 41%, thoracic gas volume of 180% pred.) and mean Pa O2 64 mm Hg by a stage 1 cycle exercise test during breathing room air (FiO2 0.21) and hyperoxic (FiO2 0.35) air. The measurements were performed by an open system using a low dead space valve (55 ml) measuring real-time breath by breath oxygen consumption (VO2) via a differential oxygen sensor, expired carbon dioxide (VCO2), ventilation (VE), oxygen pulse and oxygen saturation in both conditions. With FiO2 0.21 the mean exercise limitation was restricted to 37 (+/- 14) W and the VO2 to 11.7 (+/- 2.4) ml/kg/min with peak oxygen desaturation of 86.4 (+/- 3.2). With FiO2 0.35 the patients achieved a significant increase of workload to 55 (+/- 12.4) W and of VO2 to 14.9 (+/- 2.9) ml/kg/min. Despite the complete abolition of exercise desaturation by FIO2 0.35 the mean peak ventilation of 261/min (+/- 5.1) vs. 27 l/min (+/- 4.1) remained unaltered and therefore the restriction of the ventilatory pump limited the exercise ability. The effects of FiO2 0.35 occurred in these patients at submaximum exercise and may be related to reduction of ventilatory cost of energy and delayed onset of metabolic acidosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800956     DOI: 10.1159/000196348

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Effect of therapeutic hyperoxia on maximal oxygen consumption and perioperative risk stratification in chronic obstructive pulmonary disease.

Authors:  Hilary M Womble; Richard M Schwartzstein; Richard P Johnston; David H Roberts
Journal:  Lung       Date:  2012-01-17       Impact factor: 2.584

2.  Comparison of nasal cannulas and the OxyArm in patients requiring chronic domiciliary oxygen therapy.

Authors:  James Paul; Ted Otvos
Journal:  Can Respir J       Date:  2006 Nov-Dec       Impact factor: 2.409

3.  Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Susan S Jacobs; Jerry A Krishnan; David J Lederer; Marya Ghazipura; Tanzib Hossain; Ai-Yui M Tan; Brian Carlin; M Bradley Drummond; Magnus Ekström; Chris Garvey; Bridget A Graney; Beverly Jackson; Thomas Kallstrom; Shandra L Knight; Kathleen Lindell; Valentin Prieto-Centurion; Elisabetta A Renzoni; Christopher J Ryerson; Ann Schneidman; Jeffrey Swigris; Dona Upson; Anne E Holland
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.